Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

…,DW Denning, E Johnson, VMehra… - European …, 2020 - Eur Respiratory Soc
… Denning, Elizabeth Johnson,Varun Mehra, Tony Pagliuca, Brijesh Patel, Johanna
Rhodes, Silke Schelenz, Anand Shah, Frank L. van de Veerdonk, Paul E. Verweij, P …

[PDF][PDF]Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

…, M Zuckerman,J Vidler, S Sharif, VMehra… - Br J …, 2020 - researchgate.net
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged at the end of
2019 and caused an infection named COVID-19 (Guan, Ni et al. 2020). Patients with …

[HTML][HTML]Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia

…, P George, C Grimley, F Jack, L Munro, VMehra… - Leukemia, 2019 - nature.com
Determining the underlying cause of persistent eosinophilia is important for effective clinical
management but remains a diagnostic challenge in many cases. We identified STAT5B …

Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients

…,T Lechmere, H Khan, MH Malim, C Harrison, VMehra… - Cancer Cell, 2021 - cell.com
SARS-CoV-2 has led to unprecedented global healthcare challenges, with poor outcomes
observed in groups with immune deficiency, including allogeneic stem cell transplantation (…

Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival

…, A Bloor,A Pagliuca, V Potter, VMehra… - British journal of …, 2019 - Wiley Online Library
Mesenchymal stromal cells ( MSC s) have been successfully used for the treatment of
steroid‐resistant graft‐versus‐host‐disease (Gv HD ). However, the lack of early predictors of …

Estimating the value of demand-side management in low-cost, solar micro-grids

VMehra, R Amatya,RJ Ram- Energy, 2018 - Elsevier
需求管理ential to reduce the cost of solar based community
micro-grids and solar home systems for electricity access. This paper presents a methodology …

Early and late‐onset veno‐occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation–a real‐world UK experience

VMehra, S Tetlow, A Choy… - American Journal of …, 2021 - Wiley Online Library
Classical veno‐occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a serious
complication post allogeneic hematopoietic stem cell transplantation (HSCT). Before the …

Autologous hematopoietic stem cell transplantation in active multiple sclerosis: a real-world case series

…,O Ciccarelli,MP Sormani, E Olavarria, VMehra… - Neurology, 2021 - AAN Enterprises
Objective To examine outcomes in people with multiple sclerosis (PwMS) treated with autologous
hematopoietic stem cell transplantation (AHSCT) in a real-world setting. Methods This …

[HTML][HTML]Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 …

…, C Cordonnier,S Meylan, VMehra… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS-…

Epstein-Barr virus and monoclonal gammopathy of clinical significance in autologous stem cell transplantation for multiple sclerosis

VMehra, E Rhone, S Widya… - Clinical Infectious …, 2019 - academic.oup.com
Introduction Autologous hematopoietic stem cell transplantation (AHSCT) with anti-thymocyte
globulin (ATG) conditioning as treatment of active multiple sclerosis (MS) is rapidly …